Short answer
UnitedHealth Group (UNH) filed its Q2 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $112.0B (up 0.4% year over year) with net income of $5.5B.
Q2 2026 key financials · XBRL
- Revenue
- $112.0B
- +0.4% YoY · +0.3% QoQ
- Net income
- $5.5B
- +61.0% YoY · −12.7% QoQ
- Operating margin
- 7.1%
- EPS (diluted)
- $6.04
- +60.6% YoY · −12.5% QoQ
Source: XBRL data from the UnitedHealth Group (UNH) Q2 2026 10-Q on SEC EDGAR. USD.
UnitedHealth Group Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Four reportable segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare
Risk Factors
- No material changes to risk factors since the 2025 10-K
- Carried-forward business, financial-condition, and future-results risks remain potentially material
- Additional unknown or currently immaterial risks may adversely affect results
- Share repurchases reduced authorization to 10.6 million shares by June 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other UnitedHealth Group quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.